The role of serum and urine interleukin-8 on acute pyelonephritis and subsequent renal scarring in children. 2009

Ji-Nan Sheu, and Shan-Ming Chen, and Meng-Hsiao Meng, and Ko-Huang Lue
Department of Pediatrics, Chung Shan Medical University Hospital, Taichung, Taiwan. cshy098@csh.org.tw

BACKGROUND Interleukin (IL)-8 acts as a potent neutrophils chemoattractant responsible for the migration of neutrophils into the infected renal tissue to protect against invading pathogens. The aim of this study was to assess the role of IL-8 on acute-phase pyelonephritis and later renal scarring in children. METHODS A total of 124 children with a first-time febrile urinary tract infection (UTI) were studied. The diagnosis of acute pyelonephritis was confirmed by Tc-dimercaptosuccinic acid (DMSA) renal scan. Serum and urine samples were obtained from 124 children with UTI and 20 healthy children for IL-8 measurement. RESULTS The 124 children were divided into acute pyelonephritis (n = 70) and lower UTI (n = 54) groups according to the results of DMSA scans. The initial serum and urine IL-8 values of children with acute pyelonephritis were significantly higher when compared with lower UTI and healthy controls (all P < 0.001). Renal scarring was seen in 26 (38.8%) of these 67 children with acute pyelonephritis at follow-up DMSA scans. Both the initial serum and urine IL-8 concentrations were significantly higher in children with renal scarring than in those without (both P < 0.001). The mean age of children with renal scarring was also significantly lower than those without scarring (P = 0.004). Multivariate analysis showed that the highest initial IL-8 values, age <20 months and reflux grades > or =III all were independent predictors of renal scarring. CONCLUSIONS Those children younger than 2 years of age with the highest IL-8 concentrations during the acute phase of pyelonephritis as well as children with reflux grades of III or greater are at a high-risk for developing renal scarring in the future.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D011704 Pyelonephritis Inflammation of the KIDNEY involving the renal parenchyma (the NEPHRONS); KIDNEY PELVIS; and KIDNEY CALICES. It is characterized by ABDOMINAL PAIN; FEVER; NAUSEA; VOMITING; and occasionally DIARRHEA. Necrotizing Pyelonephritis,Pyelonephritis, Acute Necrotizing,Pyelonephritides
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002921 Cicatrix The fibrous tissue that replaces normal tissue during the process of WOUND HEALING. Scars,Cicatrization,Scar,Scarring
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014556 Urine Liquid by-product of excretion produced in the kidneys, temporarily stored in the bladder until discharge through the URETHRA.
D016209 Interleukin-8 A member of the CXC chemokine family that plays a role in the regulation of the acute inflammatory response. It is secreted by variety of cell types and induces CHEMOTAXIS of NEUTROPHILS and other inflammatory cells. CXCL8 Chemokine,Chemokine CXCL8,Chemotactic Factor, Macrophage-Derived,Chemotactic Factor, Neutrophil, Monocyte-Derived,IL-8,Neutrophil-Activating Peptide, Lymphocyte-Derived,Neutrophil-Activating Peptide, Monocyte-Derived,AMCF-I,Alveolar Macrophage Chemotactic Factor-I,Anionic Neutrophil-Activating Peptide,Chemokines, CXCL8,Chemotactic Factor, Neutrophil,Granulocyte Chemotactic Peptide-Interleukin-8,IL8,Monocyte-Derived Neutrophil Chemotactic Factor,Neutrophil Activation Factor,Alveolar Macrophage Chemotactic Factor I,Anionic Neutrophil Activating Peptide,CXCL8 Chemokines,CXCL8, Chemokine,Chemokine, CXCL8,Chemotactic Factor, Macrophage Derived,Chemotactic Peptide-Interleukin-8, Granulocyte,Granulocyte Chemotactic Peptide Interleukin 8,Interleukin 8,Lymphocyte-Derived Neutrophil-Activating Peptide,Macrophage-Derived Chemotactic Factor,Monocyte-Derived Neutrophil-Activating Peptide,Neutrophil Activating Peptide, Lymphocyte Derived,Neutrophil Activating Peptide, Monocyte Derived,Neutrophil Chemotactic Factor,Neutrophil-Activating Peptide, Anionic,Peptide, Anionic Neutrophil-Activating

Related Publications

Ji-Nan Sheu, and Shan-Ming Chen, and Meng-Hsiao Meng, and Ko-Huang Lue
September 2012, Pediatric nephrology (Berlin, Germany),
Ji-Nan Sheu, and Shan-Ming Chen, and Meng-Hsiao Meng, and Ko-Huang Lue
June 1994, Pediatric nephrology (Berlin, Germany),
Ji-Nan Sheu, and Shan-Ming Chen, and Meng-Hsiao Meng, and Ko-Huang Lue
February 1996, Acta paediatrica (Oslo, Norway : 1992),
Ji-Nan Sheu, and Shan-Ming Chen, and Meng-Hsiao Meng, and Ko-Huang Lue
December 2000, The Journal of infectious diseases,
Ji-Nan Sheu, and Shan-Ming Chen, and Meng-Hsiao Meng, and Ko-Huang Lue
February 1996, The Journal of urology,
Ji-Nan Sheu, and Shan-Ming Chen, and Meng-Hsiao Meng, and Ko-Huang Lue
January 2020, Journal of inflammation research,
Ji-Nan Sheu, and Shan-Ming Chen, and Meng-Hsiao Meng, and Ko-Huang Lue
February 1994, Archives of disease in childhood,
Ji-Nan Sheu, and Shan-Ming Chen, and Meng-Hsiao Meng, and Ko-Huang Lue
October 1994, Archives of disease in childhood,
Ji-Nan Sheu, and Shan-Ming Chen, and Meng-Hsiao Meng, and Ko-Huang Lue
May 2013, Korean journal of pediatrics,
Ji-Nan Sheu, and Shan-Ming Chen, and Meng-Hsiao Meng, and Ko-Huang Lue
March 1992, British journal of urology,
Copied contents to your clipboard!